Insiders · Profile

Firmani Lori

Chief Financial Officer at Damora Therapeutics. Filing since 3 Jan 2025. CIK 0001808248

Company
Date
Role
Action
Shares
Amount
Of holding
2 Jan 2026
Chief Financial Officer
Sold at will
135
$2.89K
12.7%
3 Jul 2025
Interim CFO
Sold at will
147
$498.33
17.5%
3 Jan 2025
Interim CFO
Sold at will
261
$1.47K
36.0%
3 decisions on file.